My Twin Communication, an agency specializing in financial communication and investor relations, announces that the Otofarma Group – with over 30 years of experience in the hearing care sector, leader in the production of hearing aids distributed mainly through the pharmaceutical channel – has chosen My Twin Communication as external advisor for investor relations activities.
My Twin Communication will support Otofarma's Management and Investor Relator through strategic consulting activities and operational support in the management of relations with the financial community, with the aim of strengthening the Company's positioning among investors, analysts and reference stakeholders.
In particular, My Twin Communication will support Otofarma in the coordination and development of communication activities aimed at the market, helping to enhance the visibility of the Company, the coherence and recognizability of the equity story, as well as the effectiveness of the dialogue with the financial community.
The Otofarma Group has been operating for over 30 years in the hearing care sector and has developed an innovative model that integrates technology, personalization and proximity of service. The Company designs, manufactures and markets customized hearing aids through a network of over 4,000 affiliated pharmacies. With a strong focus on innovation and research, Otofarma is a patent holder and has built its distinctive positioning through the development of solutions dedicated to the world of hearing.
The collaboration with My Twin Communication is part of the Group's growth and consolidation path and aims to strengthen the quality and continuity of the dialogue with the financial community, through transparent, structured communication consistent with the Company's industrial evolution.
***
My Twin Communication is an agency specialized in Financial Communication and Investor Relations, supporting listed issuers, industrial companies and institutions operating in the banking, savings and investment sectors. It develops visibility strategies aimed at the financial community, strengthening dialogue with investors, analysts, journalists and stakeholders. The company supports entrepreneurs, CEOs, CFOs as well as Investor Relators and Communication & Marketing Managers in the management of information flows and market positioning, supporting extraordinary transactions, IPOs, capital increases and reputation and perception management. It promotes transparency, liquidity and quality financial communication for the benefit of all stakeholders.
The Otofarma SpA Group is a leader in the design, production and marketing of customized hearing aids in the Pharmacy channel. It has built its reputation on technological innovation and continuous research, offering advanced audiological solutions at a guaranteed democratic price, with the aim of making access to hearing care more equitable and widespread.
A pioneer in telemedicine, Otofarma was the first company in Europe to introduce specialist teleaudiology in pharmacies: today it directly manages this service in over 4,000 affiliated pharmacies, facilitating access to diagnosis and personalisation of prostheses. Founded by Gennaro Bartolomucci, today President and CEO, the company is the owner of IT and instrumental patents. Its devices and services are distributed exclusively through partner pharmacies, guaranteeing a controlled and quality-oriented model.
For more information:
Otofarma S.p.A. - Investor relations
Anna Incarnato Bartolomucci
E-mail:
mob: +39 347 0506780
My Twin Communication S.r.l. - Investor relations Advisor
Mara Di Giorgio | +39 3357737417
Marco Messori | +39 3355985809
